Clinical Trial Update: Amino-acid PET Versus MRI Guided Re-irradiation in Patients With Recurrent Glioblastoma Multiforme [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating amino-acid PET-guided re-irradiation versus MRI-guided re-irradiation in patients with recurrent glioblastoma multiforme.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Snippet

Sponsor: University Hospital Freiburg | Conditions: Recurrent Glioma (Glioblastoma Multiforme) | Phase 2 | Status: UNKNOWN